Research & Insights
January 23, 2025
Lazard 2024 Secondary Market Report
This year, the secondary market hit a record $152 billion in volume, surpassing the previous high set in 2021.
Annual Review of Shareholder Activism 2024
Lazard’s 2024 review of shareholder activism highlights key trends and data in shareholder activism activity throughout the year.
Lazard Global Biopharmaceutical Leaders Study 2024
Biopharmaceutical and biotech investors concluded the summer of 2024 facing ongoing uncertainty.